Trade Mark Journal No.2025/002 10 January 2025

WO0000001829006 (5)

Office of origin: United States of America

Date of International Registration:3 June 2024
Date of designation in the UK: 3 June 2024
Image for mark 1829006 AMMONIAGO

International priority date claimed: 8 January 2024 (United States of America) (98346961)
Class 5
Medical diagnostic test kits for the detection of ammonia in biological fluids to either diagnose or monitor the physiological status of either inherited or acquired disorders that either influence or are influenced by ammonia metabolism, including urea cycle disorders, organic acidemias, fatty acid oxidation disorders, other metabolic disorders of ammonia metabolism, liver disease, kidney disease, renal tubular acidosis, and nephrolithiasis.

Sequitur Health Corp.

Representative: Eryn Y. Truong LOZA & LOZA, LLP, 305 N. Second Ave., #127, Upland CA 91786, UNITED STATES OF AMERICA